New GAP III guideline sets higher standards for research facilities

Published: 8-Feb-2017

The World Health Organization has a plan to limit and certify research facilities that use poliovirus which means those facilities have to implement special biocontainment measures. Bernard Melchers, Containment Consultant, Deerns Nederland, explains what is involved

You need to be a subscriber to read this article.
Click here to find out more.

Years of research into polio and the production of a vaccine have led to an almost worldwide extinction of the poliovirus. However, the now used and stored samples of the virus in research facilities form a potential risk for the reintroduction of polio.

The World Health Organization (WHO) has set up a plan to reduce the total number of research facilities that use the poliovirus to a limited number of certified research facilities. These “essential locations” must comply with specific measures to reduce the risk of polio reintroduction to a minimum.

These research facilities can only be certified when all the risk mitigation measures are implemented correctly. This article elaborates on these measures and indicates how they have to be implemented.

Polio is well known as an infectious disease against which, in large areas of the world, every citizen is vaccinated against. The virus spreads through the faeces of infected people.

This happens under circumstances relating to poor hygiene. Of the three existing polio types, type 2 is the most infectious.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.

Subscribe now Already a subscriber? Sign in here.

You may also like